- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Ice Cream.
Displaying page 1 of 1.
EudraCT Number: 2012-003638-18 | Sponsor Protocol Number: AG0112CR | Start Date*: 2013-03-13 |
Sponsor Name:Australasian Gastro-Intestinal Trials Group, Sydney University | ||
Full Title: Randomised Phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic CRC with either KRAS WT or G13D mutation. ICE CREAM: The Irinotecan Cetuximab Evaluation a... | ||
Medical condition: metastatic colorectal cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) ES (Completed) IT (Ongoing) BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-001537-92 | Sponsor Protocol Number: RHMCHI0714 | Start Date*: 2014-07-02 | |||||||||||
Sponsor Name:University Hospital Southampton NHS Foundation Trust | |||||||||||||
Full Title: Safety of Nasal Influenza Immunisation in Egg Allergic Children - The SNIFFLE 2 study | |||||||||||||
Medical condition: Children aged 24 months to (and including) 17 years with IgE-mediated food allergy to egg protein | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000048-23 | Sponsor Protocol Number: P2-IMU-838-PMS | Start Date*: 2021-11-04 | |||||||||||
Sponsor Name:Immunic AG | |||||||||||||
Full Title: Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients with Progressive Multiple Sclerosis | |||||||||||||
Medical condition: Progressive forms of Multiple Sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Ongoing) BG (Ongoing) DE (Ongoing) NL (Ongoing) RO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003558-17 | Sponsor Protocol Number: TRx-237-039 | Start Date*: 2018-02-25 | |||||||||||
Sponsor Name:TauRx Therapeutics Ltd | |||||||||||||
Full Title: Randomized, Double-Blind, Placebo-Controlled, Three-Arm, 12-Month, Safety and Efficacy Study of Hydromethylthionine Mesylate (LMTM) Monotherapy in Subjects with Alzheimer's Disease Followed by a 12... | |||||||||||||
Medical condition: Alzheimer’s Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) BE (Completed) PL (Completed) ES (Ongoing) FR (Completed) IT (Ongoing) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.